DME Capital Management’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Sell
1,651,150
-1,080,660
-40% -$57.8M 2.71% 9
2026
Q1
$89.4M Buy
2,731,810
+92,390
+4% +$3.79M 2.8% 12
2025
Q4
$109M Buy
2,639,420
+1,078,880
+69% +$40.4M 3.81% 8
2025
Q3
$55.7M Buy
1,560,540
+721,370
+86% +$21.8M 2.19% 15
2025
Q2
$45.6M Buy
839,170
+291,600
+53% +$17.1M 1.96% 18
2025
Q1
$33.2M Sell
547,570
-322,930
-37% -$19.5M 1.68% 16
2024
Q4
$52.7M Buy
+870,500
New +$54.3M 2.71% 11

Other funds holding CNC

DME Capital Management's CNC Position: Q2 2026 in Review

DME Capital Management reduced its Centene (CNC) stake by 40% in Q2 2026, selling an estimated $57.8M and leaving 1,651,150 shares worth $106M. The position accounts for 2.71% of the portfolio, ranked #9.

DME Capital Management first reported a position in CNC in Q4 2024 and has held it in 7 quarters since. The position peaked at $109M in Q4 2025. 1,006 funds tracked by Wall St. Rank hold CNC as of Q2 2026.

  • DME Capital Management held 1,651,150 shares of Centene worth $106M as of Q2 2026.
  • DME Capital Management sold 1,080,660 Centene shares in Q2 2026, an estimated $57.8M.
  • Centene made up 2.71% of DME Capital Management's portfolio in Q2 2026, its #9 holding.
  • DME Capital Management first reported a position in Centene in Q4 2024 and has held it in 7 quarters since.
  • DME Capital Management's Centene position peaked at $109M in Q4 2025.
  • 1,006 funds tracked by Wall St. Rank held Centene as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.